JENNY BICH-HANH LE-PREJEAN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ROCKVILLE, MD NPI 1982204160

General Payments — all program years on this page

$6,809.77

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $528.70 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $468.7117
Education $59.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $190.554
ABBVIE INC. $137.326
Amgen Inc. $73.754
Janssen Biotech, Inc. $59.991
Pacira Pharmaceuticals Incorporated $36.251
Lilly USA, LLC $17.381
Genentech USA, Inc. $13.461

By program year

Program yearAmountRecords
2021 $27.531
2022 $1,329.5514
2023 $4,923.9947
2024 $528.7018

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078728853 Janssen Biotech, Inc. $59.99 03/19/2024 Education Undisputed 01/23/2026 View at CMS
1104243757 AstraZeneca Pharmaceuticals LP $21.49 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104309792 AstraZeneca Pharmaceuticals LP $73.23 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104395379 AstraZeneca Pharmaceuticals LP $81.90 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105781410 AstraZeneca Pharmaceuticals LP $13.93 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107517331 ABBVIE INC. $6.02 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107517333 ABBVIE INC. $101.17 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107517335 ABBVIE INC. $4.99 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107517337 ABBVIE INC. $11.90 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107517339 ABBVIE INC. $8.96 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107517341 ABBVIE INC. $4.28 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115866174 Amgen Inc. $18.33 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115866184 Amgen Inc. $19.44 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115866192 Amgen Inc. $21.76 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115866200 Amgen Inc. $14.22 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133145829 Genentech USA, Inc. $13.46 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135716382 Lilly USA, LLC $17.38 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151263279 Pacira Pharmaceuticals Incorporated $36.25 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.